Third Grade Cancer Survivor Posts Video Tips to Newly Diagnosed Football Player
Jake Daniel is a third grader who was diagnosed with non-Hodgkin's lymphoma in December.
By May he had battled through chemotherapy, so when the seven year-old football fan heard about the Houston Texans' David Quessenberry, the 300 lb National Football League player who was recently diagnosed with non-Hodgkin's lymphoma, Jake decided to make a how-to video of sorts on getting through the ups and downs of chemotherapy for Quessenberry. He posted the video on YouTube.
Among his tips to the pro football player:
- Always keep your head up
- Never give up
- When you get the mouth sores, always eat Jell-O
- Always flirt with nurses
Quessenberry saw the boy's YouTube video and was inspired enough to send him a tweet, saying "Jake, you just made my day my friend. Wise words, young stud, can't wait to meet you."
Source: USA Today
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
